241 related articles for article (PubMed ID: 21810188)
1. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
[TBL] [Abstract][Full Text] [Related]
2. Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol.
Caruso S; Iraci Sareri M; Agnello C; Romano M; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 May; 8(5):1478-85. PubMed ID: 21324086
[TBL] [Abstract][Full Text] [Related]
3. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
4. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
[TBL] [Abstract][Full Text] [Related]
5. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
6. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
7. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol valerate and dienogest on quality of life and sexual function according to age.
Di Carlo C; Gargano V; De Rosa N; Tommaselli GA; Sparice S; Nappi C
Gynecol Endocrinol; 2014; 30(12):925-8. PubMed ID: 25366390
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
[TBL] [Abstract][Full Text] [Related]
10. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Nappi RE
Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
[TBL] [Abstract][Full Text] [Related]
12. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
13. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
[TBL] [Abstract][Full Text] [Related]
14. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
[TBL] [Abstract][Full Text] [Related]
15. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
Contraception; 2003 Jan; 67(1):25-32. PubMed ID: 12521654
[TBL] [Abstract][Full Text] [Related]
16. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
[TBL] [Abstract][Full Text] [Related]
17. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
19. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
[TBL] [Abstract][Full Text] [Related]
20. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
